(c) 2024 PillSync.com

levothyroxine sodium 50 ug

1 INDICATIONS AND USAGE Hypothyroidism Levothyroxine sodium tablets are indicated as a replacement therapy in primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) congenital or acquired hypothyroidism. Pituitary Thyrotropin (Thyroid ‑ Stimulating Hormone, TSH) Suppression Levothyroxine sodium tablets are indicated as an adjunct to surgery and radioiodine therapy in the management of thyrotropin-dependent well-differentiated thyroid cancer. • Limitations of Use: • Levothyroxine sodium tablets are not indicated for suppression of benign thyroid nodules and nontoxic diffuse goiter in iodine-sufficient patients as there are no clinical benefits and overtreatment with levothyroxine sodium may induce hyperthyroidism [see Warnings and Precautions (5.4) ] . • Levothyroxine sodium tablets are not indicated for treatment of hypothyroidism during the recovery phase of subacute thyroiditis. Levothyroxine sodium tablets are levothyroxine sodium (T4) indicated for: • Hypothyroidism: As replacement therapy in primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) congenital or acquired hypothyroidism. (1) • Pituitary Thyrotropin (Thyroid‑Stimulating Hormone, TSH) Suppression: As an adjunct to surgery and radioiodine therapy in the management of thyrotropin-dependent well-differentiated thyroid cancer. (1) Limitations of Use: • - not indicated for suppression of benign thyroid nodules and nontoxic diffuse goiter in iodine-sufficient patients. • - Not indicated for treatment of hypothyroidism during the recovery phase of subacute thyroiditis.

Proficient Rx LP


2 years ago ROUND WHITE P 2 levothyroxine sodium 50 ug

ROUND WHITE P 2

2 years ago ROUND WHITE P 2 levothyroxine sodium 50 ug

P 2 ROUND WHITE

16 HOW SUPPLIED/STORAGE AND HANDLING All tablets having functional scoring.

LEVOTHYROXINE SODIUM, USP tablets are supplied as follows: Strength (mcg) Tablet Description NDC# for bottles with child-resistant closure of 30 NDC# for bottles with child-resistant closure of 60 NDC# for bottles with child-resistant closure of 90 50 round shaped, white colored, uncoated tablets, break line on both side and debossed with "P" and "2" on one side and plain on other side. 71205-646-30 71205-646-60 71205-646-90 Storage Conditions Store at 25°C (77°F); excursions permitted to 15° to 30° C (59° to 86° F) [see USP Controlled Room Temperature].

LEVOTHYROXINE SODIUM tablets should be protected from light and moisture.


More pills like ROUND P 2

Related Pills

levothyroxine 50 ug

accord healthcare inc.

levothyroxine 50 ug

accord healthcare inc.

Hydromorphone Hydrochloride 2 MG Oral Tablet

Rhodes Pharmaceuticals L.P.

Hydromorphone Hydrochloride 2 MG Oral Tablet

Rhodes Pharmaceuticals L.P.

SMX 800 MG TMP 160 MG Oral Tablet

Major Pharmaceuticals

SMX 800 MG TMP 160 MG Oral Tablet

Major Pharmaceuticals

Vimpat 200 MG Oral Tablet

Kremers Urban Pharmaceuticals Inc

Hydromorphone Hydrochloride 2 MG Oral Tablet

Rhodes Pharmaceuticals L.P.












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site